InvestorsHub Logo

EZ2

03/09/11 3:56 PM

#28198 RE: Tulaz1 #28197

Semi-decent volume again today ---- sure wish we could get the price turned around.

Unfortunately, if the IHUB 'trades' tab is accurate......about 99% of the volume today is on SELL side !

If/when this puppy gets some legs under it......going to be lots of fun !

EZ2

03/10/11 7:35 AM

#28201 RE: Tulaz1 #28197

Anyone from MMR Global attending ?

===============================================

Celgene Corporation to Present at Barclays Capital 2011 Global Healthcare Conference

03/10 07:30 AM



SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (CELG:$53.65,00$-0.42,00-0.78%) today announced its presentation at Barclays Capital 2011 Global Healthcare Conference onTuesday, March 15, 2011 at 1:30 p.m. ET will be webcast live and will be available in the investor relations section of the company’s Web site at www.celgene.com. Celgene (CELG:$53.65,00$-0.42,00-0.78%) management will provide an overview of the company.

Celgene Corporation (CELG:$53.65,00$-0.42,00-0.78%) , headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company’s Web site at www.celgene.com.

This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the company’s control. The company’s actual results, performance, or achievements could be materially different from those projected by these forward-looking statements. The factors that could cause actual results, performance, or achievements to differ from the forward-looking statements are discussed in the company’s filings with the Securities and Exchange Commission, such as the company’s Form 10-K, 10-Q and 8-K reports. Given these risks and uncertainties, you are cautioned not to place undue reliance on the forward-looking statements.

Source: Celgene Corporation (CELG:$53.65,00$-0.42,00-0.78%)